Flex Pharma, Inc.·4

Jun 18, 4:08 PM ET

McVicar William K. 4

4 · Flex Pharma, Inc. · Filed Jun 18, 2018

Insider Transaction Report

Form 4
Period: 2018-06-14
McVicar William K.
President, R&D
Transactions
  • Award

    Stock Option (right to buy)

    2018-06-14+359,696359,696 total
    Exercise: $1.35Exp: 2028-06-14Common Stock (359,696 underlying)
Footnotes (1)
  • [F1]The stock option will vest in 48 successive equal monthly installments measured from June 14, 2018.

Documents

2 files